|
Tolvaptan impurity 4
|
托伐普坦雜質(zhì)4
|
176970-21-1
|
|
Pimavanserin Impurity 12
|
匹莫范色林雜質(zhì)12
|
84697-13-2
|
|
Lasmiditan Impurity SE
|
拉米地坦雜質(zhì)SE
|
|
|
Galantamine impurity 7
|
加蘭他敏雜質(zhì)7
|
21041-10-1
|
|
Pyridoxine Impurity 6
|
吡哆醇雜質(zhì)6
|
19203-56-6
|
|
Ilutinib impurity 3
|
依魯替尼雜質(zhì)3
|
1839099-22-7
|
|
Sofosbuvir Impurity 29
|
索非布韋雜質(zhì)29
|
1911578-88-5
|
|
Canagliflozin monohydrate
|
卡格列凈一水合物
|
1809403-05-1
|
|
Doxorubicin EP Impurity A
|
多柔比星EP雜質(zhì)A
|
20830-81-3
|
|
Roxatidine Impurity 2 HCl
|
羅沙替丁雜質(zhì)2鹽酸鹽
|
195621-06-8
|
|
Methylphenidate impurity 2
|
哌甲酯雜質(zhì)2
|
19395-39-2
|
|
Argatroban Impurity 55
|
阿加曲班雜質(zhì)55
|
1780572-69-1
|
|
Brexpiprazole Impurity 59
|
依匹哌唑雜質(zhì)59
|
1849603-58-2
|
|
Ergosterol Impurity 4
|
麥角甾醇雜質(zhì)4
|
2061-64-5
|
|
Oseltamivir Impurity145
|
奧司他韋雜質(zhì)145
|
204254-98-8
|
|
Edoxaban Impurity 89
|
依度沙班雜質(zhì)89
|
17899-48-8
|
|
Mexobamol impurity 2
|
美索巴莫雜質(zhì)2
|
2049-21-0
|
|
Potassium clavulanate impurity 13
|
克拉維酸鉀雜質(zhì)13
|
2015-16-9
|
|
Brimonidine EP impurity E hydrochloride
|
溴莫尼定EP雜質(zhì)E鹽酸鹽
|
1797986-78-7
|
|
Lapatinib Impurity 23
|
拉帕替尼雜質(zhì)23
|
202197-27-1
|
|
Oryzanol impurity 3
|
谷維素雜質(zhì)3
|
20972-10-5
|
|
Palbociclib Impurity 30
|
帕布昔利布雜質(zhì)30
|
1974279-21-4
|
|
Anagrelide impurity 10
|
阿那格雷雜質(zhì)10
|
17700-09-3
|
|
Ethyl 1h-indazole-5-carboxylate
|
1H-吲唑-5-甲酸乙酯
|
192944-51-7
|
|
Oryzanol impurity 10
|
谷維素雜質(zhì)10
|
20972-08-1
|
|
Mitiglinide (calcium salt, hydrate)
|
米格列奈(鈣鹽,水合物)
|
207844-01-7
|
|
Irotinib impurity 2
|
依魯替尼雜質(zhì)2
|
2052279-49-7
|
|
Metformin Impurity 10
|
二甲雙胍雜質(zhì)10
|
178671-73-3
|
|
Levothyroxine EP Impurity H
|
左旋甲狀腺素EP雜質(zhì)H
|
2055-97-2
|
|
Lummakato impurities4
|
魯瑪卡托雜質(zhì)4
|
|
|
Topiramate EP Impurity A(Diacetonefructose)
|
托吡酯EP雜質(zhì)A(果糖二丙酮、托吡酯相關(guān)化合物A)
|
20880-92-6
|
|
Lasmiditan Impurity 15
|
拉米地坦雜質(zhì)15
|
1903-67-9
|
|
Isoniazid impurity 1
|
異煙肼雜質(zhì)1（三氮唑）
|
38634-05-8
|
|
Drotaverine Impurity 21
|
屈他維林雜質(zhì)21
|
2050-46-6
|
|
Anagrelide impurity 11
|
阿那格雷雜質(zhì)11
|
20098-48-0
|
|
Famotidine EP Impurity J HCl
|
法莫替丁EP雜質(zhì)J鹽酸鹽
|
1798006-30-0
|
|
Levosalbutamol hydrochloride USP related compound A
|
鹽酸左旋沙丁胺醇USP相關(guān)化合物A
|
1823256-56-9
|
|
Tedizolid Impurity 2
|
特地唑胺雜質(zhì)2
|
2095840-91-6
|
|
Topiroxostat Impurity 3
|
托匹司他雜質(zhì)3
|
2044704-74-5
|
|
Sofosbuvir Impurity 28
|
索非布韋雜質(zhì)28
|
1946820-91-2
|
|
Vitamin K2 Impurity 3
|
維生素K2雜質(zhì)3
|
20962-84-9
|
|
Orlistat Impurity 44
|
奧利司他雜質(zhì)44
|
19740-72-8
|
|
Cyclosporin Impurity 5
|
環(huán)孢菌素雜質(zhì)5
|
1907654-63-0
|
|
Indobufen Impurity 5
|
吲哚布芬雜質(zhì)5
|
1823992-40-0
|
|
Amentoflavone
|
毛異黃酮
|
20575-57-9
|
|
1,1,1-tribromoacetone
|
1,1,1-三溴丙酮
|
3770-98-7
|
|
Galantamine impurity 9
|
加蘭他敏雜質(zhì)9
|
199014-26-1
|
|
Sacubitril impurity 17
|
沙庫巴曲雜質(zhì)17
|
1884269-07-1
|
|
(E)-Ethyl N-hydroxyacetimidate
|
(E)-N-羥基乙酰亞胺酸乙酯
|
20703-41-7
|
|
Tedizolid Impurity 1
|
特地唑胺雜質(zhì)1
|
2044712-34-5
|
|
p-methyl cinnamic acid
|
對甲基肉桂酸
|
1866-39-3
|
|
Methylphenidate EP impurity A (racemate)
|
哌甲酯EP雜質(zhì)A（消旋體）
|
19395-41-6
|
|
Levothyroxine EP Impurity I
|
左旋甲狀腺素EP雜質(zhì)I
|
2016-06-0
|
|
Etocoxib impurity 11
|
依托考昔雜質(zhì)11
|
202409-31-2
|
|
Tenofovir Impurity 59
|
替諾福韋雜質(zhì)59
|
1796545-19-1
|
|
Bendamustine Impurity 33
|
苯達莫司汀雜質(zhì)33
|
1869075-89-7
|
|
Ceftizoxime Impurity 56
|
頭孢唑肟雜質(zhì)56
|
1824820-93-0
|
|
Escitalopram Impurity 34
|
艾司西酞普蘭雜質(zhì)34
|
1881237-26-8
|
|
Rivaroxaban Impurity 88
|
利伐沙班雜質(zhì)88
|
1794804-53-7
|
|
Apixaban Impurity 41
|
阿哌沙班雜質(zhì)41
|
1777782-32-7
|
|
Warfarin EP Impurity C
|
華法林EP雜質(zhì)C
|
1896-62-4
|
|
Pyridoxine Impurity 12
|
吡哆醇雜質(zhì)12
|
1805775-66-9
|
|
Thiamine EP Impurity C
|
硫胺素EP雜質(zhì)C
|
20166-17-0
|
|
Lysine impurity 33
|
賴氨酸雜質(zhì)33
|
19460-99-3
|
|
Eltrombopag Impurity 66
|
艾曲波帕雜質(zhì)66
|
18048-64-1
|
|
Warfarin Impurity 18
|
華法林雜質(zhì)18
|
17834-03-6
|
|
2 - (aminooxy) acetic acid hydrochloride
|
2-(氨基氧基)乙酸鹽酸鹽
|
20295-82-3
|
|
Lapatinib Impurity 15
|
拉帕替尼雜質(zhì)15
|
179246-45-8
|
|
Tofatinib Impurity 34（HCI)
|
托法替尼雜質(zhì)34（HCI)
|
1821769-41-8
|
|
Amikacin Impurity 17
|
阿米卡星雜質(zhì)17
|
1793053-90-3
|
|
Tetrabutylammonium hydroxide
|
四丁基氫氧化銨
|
2052-49-5
|
|
Oxytetracycline EP impurity D
|
土霉素EP雜質(zhì)D
|
18695-01-7
|
|
Indobufen Impurity 6
|
吲哚布芬雜質(zhì)6
|
1781917-78-9
|
|
Oseltamivir Impurity147
|
奧司他韋雜質(zhì)147
|
204255-02-7
|
|
Urapidil Impurity 38
|
烏拉地爾雜質(zhì)38
|
21103-25-3
|
|
Mirtazapine EP Impurity C
|
米氮平EP雜質(zhì)C
|
191546-96-0
|
|
Pemetrexed Impurity 2
|
培美曲塞雜質(zhì)2
|
193281-00-4
|
|
Hydroxyasiatic acid
|
羥基積雪草酸
|
18449-41-7
|
|
Rosuvastatin Impurity 115
|
瑞舒伐他汀雜質(zhì)115
|
1821422-50-7
|
|
Metronidazole Impurity 26
|
甲硝唑雜質(zhì)26
|
19182-82-2
|
|
Pyridoxine Impurity 8
|
吡哆醇雜質(zhì)8
|
19203-53-3
|
|
Mometasone Furoate Impurity 3
|
糠酸莫米松雜質(zhì)3
|
201601-32-3
|
|
Amlodipine Impurity 85
|
氨氯地平雜質(zhì)85
|
194472-27-0
|
|
Finerenone impurity 3
|
非奈利酮雜質(zhì)3
|
2084136-51-4
|
|
Topiroxostat Impurity 4
|
托匹司他雜質(zhì)4
|
2044702-36-3
|
|
Terbinafine EP Impurity C
|
特比萘芬EP雜質(zhì)C
|
187540-01-8
|
|
1,2-diaminopropane dihydrochloride
|
1,2-二氨基丙烷 二鹽酸鹽
|
19777-67-4
|
|
Atorvastatin Impurity 51
|
阿托伐他汀雜質(zhì)51
|
1817798-20-1
|
|
Anagrelide impurity 20
|
阿那格雷雜質(zhì)20
|
183620-20-4
|
|
Ethyl eicosapentetraenolate
|
二十碳四烯酸乙酯
|
1808-26-0
|
|
Rivaroxaban Impurity 89
|
利伐沙班雜質(zhì)89
|
19532-96-8
|
|
(E)-3-(3,4-Bis((tert-butyldimethylsilyl)oxy)phenyl)acrylic acid
|
(E)-3-(3,4-雙((叔丁基二甲基硅烷基)氧基)苯基)丙烯酸
|
203118-32-5
|
|
Amoxicillin Impurity 40
|
阿莫西林雜質(zhì)40(指定BP品牌：748）
|
|
|
L-valinol
|
L-纈氨醇
|
2026-48-4
|
|
Tenofovir Impurity 62
|
替諾福韋雜質(zhì)62
|
1962114-92-6
|
|
2,4,4 '- trichlorobiphenyl
|
2,4,4′-三氯聯(lián)苯
|
7012-37-5
|
|
Norepinephrine EP impurity f hydrochloride salt
|
去甲腎上腺素EP雜質(zhì)F鹽酸鹽
|
20455-68-9
|
|
Oxytetracycline EP impurity E
|
土霉素EP雜質(zhì)E
|
18751-99-0
|
|
Diphenhydramine EP Impurity C HCl
|
苯海拉明EP雜質(zhì)C鹽酸鹽
|
1808-12-4
|
|
Propionate methanesulflate
|
甲磺酸丙酯
|
1912-31-8
|